Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study

A. Delameillieure (Leuven, Belgium), F. Dobbels (Leuven, Belgium), K. Leceuvre (Leuven, Belgium), D. Strens (Leuven, Belgium), P. Simaels (Leuven, Belgium), K. Verheyen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), W. Wuyts (Leuven, Belgium)

Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Session: Natural history and management of interstitial lung diseases of known cause
Session type: E-poster session
Number: 1816

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Delameillieure (Leuven, Belgium), F. Dobbels (Leuven, Belgium), K. Leceuvre (Leuven, Belgium), D. Strens (Leuven, Belgium), P. Simaels (Leuven, Belgium), K. Verheyen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), W. Wuyts (Leuven, Belgium). Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study. 1816

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: